Apolipoprotein E genotype and statins affect CRP levels through independent and different mechanisms: AGES-Reykjavik Study
Authors:
- Gudny EiriksdottirGEGudny Eiriksdottir
- Thor AspelundTAThor Aspelund
- Kristjana BjarnadottirKBKristjana Bjarnadottir
- Elin OlafsdottirEOElin Olafsdottir
- Lenore J. LaunerLLLenore J. Launer
- Tamara B. HarrisTHTamara B. Harris
- Vilmundur GudnasonVGVilmundur Gudnason
- 1 May 2006
- journal article
- other
- Published by Elsevier in Atherosclerosis
- Vol. 186 (1) , 222-224
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Relative Efficacy of Atorvastatin 80 mg and Pravastatin 40 mg in Achieving the Dual Goals of Low-Density Lipoprotein Cholesterol <70 mg/dl and C-Reactive Protein <2 mg/lJACC, 2005
- New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individualsAtherosclerosis, 2004
- Heritability of C‐Reactive Protein and Association with Apolipoprotein E Genotypes in Japanese AmericansAnnals of Human Genetics, 2004
- C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart DiseaseNew England Journal of Medicine, 2004
- Erythrocyte Sedimentation Rate, an Independent Predictor of Coronary Heart Disease in Men and Women: The Reykjavik StudyAmerican Journal of Epidemiology, 2003
- Apolipoprotein E polymorphism and C-reactive protein in dyslipidemic middle-aged menAtherosclerosis, 2001